-
Je něco špatně v tomto záznamu ?
Phagocytosis-Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
M. Hortová-Kohoutková, F. Tidu, M. De Zuani, V. Šrámek, M. Helán, J. Frič
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- cytokiny imunologie MeSH
- fagocytóza * MeSH
- imunosupresivní léčba * MeSH
- lidé MeSH
- sepse imunologie patologie MeSH
- signální transdukce imunologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.
Institute of Hematology and Blood Transfusion Prague Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004829
- 003
- CZ-PrNML
- 005
- 20220228092541.0
- 007
- ta
- 008
- 220113s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/SHK.0000000000001541 $2 doi
- 035 __
- $a (PubMed)32516170
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hortová-Kohoutková, Marcela $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
- 245 10
- $a Phagocytosis-Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention / $c M. Hortová-Kohoutková, F. Tidu, M. De Zuani, V. Šrámek, M. Helán, J. Frič
- 520 9_
- $a Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cytokiny $x imunologie $7 D016207
- 650 _2
- $a lidé $7 D006801
- 650 17
- $a imunosupresivní léčba $7 D007165 $2 czmesh
- 650 12
- $a fagocytóza $7 D010587
- 650 _2
- $a sepse $x imunologie $x patologie $7 D018805
- 650 _2
- $a signální transdukce $x imunologie $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tidu, Federico $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a De Zuani, Marco $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Šrámek, Vladimír $u Department of Anesthesiology and Intensive Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Helán, Martin $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Anesthesiology and Intensive Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Frič, Jan $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $w MED00158650 $t Shock (Augusta, Ga.) $x 1540-0514 $g Roč. 54, č. 5 (2020), s. 606-614
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32516170 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220228092540 $b ABA008
- 999 __
- $a ok $b bmc $g 1752124 $s 1155978
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 54 $c 5 $d 606-614 $e - $i 1540-0514 $m Shock $n Shock $x MED00158650
- LZP __
- $a Pubmed-20220113